Dergi makalesi Açık Erişim
Pirkevi, C.; Lesage, S.; Condroyer, C.; Tomiyama, H.; Hattori, N.; Ertan, S.; Brice, A.; Basak, A. N.
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"> <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/40951</identifier> <creators> <creator> <creatorName>Pirkevi, C.</creatorName> <givenName>C.</givenName> <familyName>Pirkevi</familyName> <affiliation>Bogazici Univ, Dept Mol Biol & Genet, Neurodegenerat Res Lab, TR-34342 Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Lesage, S.</creatorName> <givenName>S.</givenName> <familyName>Lesage</familyName> </creator> <creator> <creatorName>Condroyer, C.</creatorName> <givenName>C.</givenName> <familyName>Condroyer</familyName> </creator> <creator> <creatorName>Tomiyama, H.</creatorName> <givenName>H.</givenName> <familyName>Tomiyama</familyName> <affiliation>Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan</affiliation> </creator> <creator> <creatorName>Hattori, N.</creatorName> <givenName>N.</givenName> <familyName>Hattori</familyName> <affiliation>Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan</affiliation> </creator> <creator> <creatorName>Ertan, S.</creatorName> <givenName>S.</givenName> <familyName>Ertan</familyName> <affiliation>Univ Istanbul, Dept Neurol, Cerrahpasa Fac Med, TR-34098 Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Brice, A.</creatorName> <givenName>A.</givenName> <familyName>Brice</familyName> </creator> <creator> <creatorName>Basak, A. N.</creatorName> <givenName>A. N.</givenName> <familyName>Basak</familyName> <affiliation>Bogazici Univ, Dept Mol Biol & Genet, Neurodegenerat Res Lab, TR-34342 Istanbul, Turkey</affiliation> </creator> </creators> <titles> <title>A Lrrk2 G2019S Mutation Carrier From Turkey Shares The Japanese Haplotype</title> </titles> <publisher>Aperta</publisher> <publicationYear>2009</publicationYear> <dates> <date dateType="Issued">2009-01-01</date> </dates> <resourceType resourceTypeGeneral="Text">Journal article</resourceType> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/40951</alternateIdentifier> </alternateIdentifiers> <relatedIdentifiers> <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1007/s10048-009-0173-5</relatedIdentifier> </relatedIdentifiers> <rightsList> <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights> <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights> </rightsList> <descriptions> <description descriptionType="Abstract">The leucine-rich repeat kinase 2 (LRRK2) G2019S mutation is recognized as the most common cause of familial autosomal dominant and also sporadic forms of Parkinson disease (PD). A common founder has been described for most Europeans and all North Africans and Jews; besides, two distinct G2019S LRRK2 haplotypes were found in a small proportion of European families and in Japanese PD patients. This study revealed a Turkish patient heterozygous for the G2019S mutation sharing the Japanese haplotype. To the best of our knowledge, it is the first time that the G2019S-associated Japanese haplotype has been reported in a different population.</description> </descriptions> </resource>
Görüntülenme | 28 |
İndirme | 9 |
Veri hacmi | 1.9 kB |
Tekil görüntülenme | 28 |
Tekil indirme | 8 |